Educational Paper: Formulation-related issues in pediatric clinical pharmacology

European Journal of Pediatrics

Volumn 172, Issue 6, 2013, Pages 717-720

  Tuleu, Catherine ^a   Breitkreutz, Joerg ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Biopharmaceutics; Dosage forms; Drug delivery; Drug formulations; Palatability

Indexed keywords

EXCIPIENT; ISONIAZID; LOPINAVIR PLUS RITONAVIR;

BIOEQUIVALENCE; CLINICAL PHARMACOLOGY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG TREATMENT FAILURE; DRY POWDER INHALER; HUMAN; MEDICATION ERROR; METERED DOSE INHALER; PALATABILITY; PRIORITY JOURNAL; REVIEW; TABLET;

BIOPHARMACEUTICS; CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HUMANS; PEDIATRICS; TASTE;

EID: 84878701667     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-012-1872-8     Document Type: Review

References (35)

1. Allegaert K, Anderson BJ, Vrancken M, Debeer A, Desmet K, Cosaert K, Tibboel, Devlieger H (2006) Impact of a paediatric vial on the magnitude of systematic medication errors in neonates. Paediatr Perin Drug Ther 7(2):59-63. doi: 10.1185/146300906X105096
2. Amidon GL, Walgreen CR Jr (2011) Is there a need for a pediatric BCS? In: Meeting minute of Best Pharmaceuticals for Children Act Pediatric Formulations Initiative Workshop November 1-2, 2011 Bolger Center Potomac, MD.Available via http://bpca.nichd.nih.gov/collaborativeefforts/upload/PFI-Workshop-11-1-2-11. pdf. Accessed 06 September 2012: p 6-7
3. Best BM, Capparelli EV, Diep H, Rossi SS, Farrell MJ, Williams E, Lee G, van den Anker JN, Rakhmanina N (2011) Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children. J Acquir Immune Defic Syndr 58:385-391. doi: 10.1097/QAI.0b013e318232b057
4. Breitkreutz J (2008) European perspectives on pediatric formulations. Clin Ther 30:2146-2154. doi: 10.1016/j.clinthera.2008.11.016
5. Breitkreutz J, Boos J (2007) Paediatric and geriatric drug delivery. Exp Opin Drug Deliv 4:37-45. doi: 10.1517/17425247.4.1.37
6. Chen ML, Straughn AB, Sadrieh N, Meyer M, Faustino PJ, Ciavarella AB, Meibohm B, Yates CR, Hussain AS (2007) A modern view of excipient effects on bioequivalence: case study of sorbitol. Pharm Res 24:73-80. doi: 10.1007/s11095-006-9120-4
7. Clapham D, Kirsanov D, Legin A, Rudnitskaya A, Saunders K (2012) Assessing taste without using humans: rat brief access aversion model and electronic tongue. Int J Pharm 435:137-139. doi: 10.1016/j.ijpharm.2012.05.056
8. Cram A, Breitkreutz J, Desset-Brèthes S, Nunn AJ, Tuleu C (2009) Challenges of developing palatable oral paediatric formulations. Int J Pharm 365:1-3. doi: 10.1016/j.ijpharm.2008.09.015
9. EMA/CHMP/QWP/180157/2011 (2011) Draft guideline on pharmaceutical development of medicines for paediatric use. Available via http://www.ema. europa.eu/docs/en-GB/document-library/Scientific-guideline/2011/06/WC500107908. pdf, last Accessed 06 september 2012
10. EMA/CHMP/SWP/888239/201 (2012) Concept paper on the need for revision of the guideline on excipients in the label and package leaflet of medicinal products for human use (CPMP/463/00). Available via http://www.ema.europa.eu/ docs/en-GB/document-library/Scientific-guideline/2012/03/WC500123804.pdf
11. EMEA CPMP/PWP/EWP/1401/98 Rev.1/Corr** (2010) Guideline on the investigation of bioequivalence Available via http://www.emea.europa.eu/ docs/en-GB/document-library/Scientific-guideline/2010/01/WC500070039.pdf Accessed 06 september 2012
12. EMEA/536810/2008 (2010) Guideline on the investigation of medicinal products in the term and preterm neonate Available via http://www.ema.europa.eu/ docs/en-GB/document-library/Scientific-guideline/2009/09/WC500003750.pdf last Accessed 06 september 2012
13. EMEA/CHMP/PEG/194810/2005 (2006) Reflection paper: formulations of choice for the paediatric population. Available via http://www.ema.europa.eu/docs/en- GB/document-library/Scientific-guideline/2009/09/WC500003782.pdf Accessed 06 september 2012
14. Ernest TB, Craig J, Nunn A, Salunke S, Tuleu C, Breitkreutz J, Alex R, Hempenstall J (2012) Preparation of medicines for children - a hierarchy of classification. Int J Pharm 435:124-130. doi: 10.1016/j.ijpharm.2011.06.040
15. Gaudette NJ, Pickering GJ (2012) The efficacy of bitter blockers on health-relevant bitterants. J Funct Foods 4:177-184. doi: 10.1016/j.jff.2011.10. 003
16. Gilbertson TA, Damak S, Margolskee RF (2000) The molecular physiology of taste transduction. Curr Opin Neurobiol 10:519-527. doi: 10.1016/S0959-4388(00) 00118-5
17. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE (2003) Developmental pharmacology - drug disposition, action, and therapy in infants and children. N Engl J Med 349:1157-1167. doi: 10.1056/NEJMra035092
18. Krause J, Breitkreutz J (2008) Improving drug delivery in pediatric medicine. Pharm Med 22:41-50. doi: 10.1007/BF03256681
19. Kulo A, de Hoon JN, Allegaert K (2012) The propylene glycol research project to illustrate the feasibility and difficulties to study toxicokinetics in neonates. Int J Pharm 435:112-114. doi: 10.1016/j.ijpharm.2012.05.014
20. Notterman DA, Nardi M, Saslow JG (1986) Effect of dose formulation on isoniazid absorption in two young children. Pediatrics 77:850-852
21. Pandit S, Shah U, Kirby DJ, Nunn T, Tuleu C (2010) Inappropriate oral formulations and information in paediatric trials. Arch Dis Child 95:754-756. doi: 10.1136/adc.2009.175661
22. Richey RH, Craig JV, Shah UU, Ford JL, Barker CE, Peak M, Nunn AJ, Turner MA (2012) The manipulation of drugs to obtain the required dose: systematic review. J Adv Nurs 68:2103-2112. doi: 10.1111/j.1365-2648.2011.05916.x
23. Salunke S, Giacoia G, Tuleu C (2012) The STEP (safety and toxicity of excipients for paediatrics) database. Part 1 - a need assessment study. Int J Pharm 435:101-111. doi: 10.1016/j.ijpharm.2012.05.004
24. Shehab N, Lewis CL, Streetman DD, Donn SM (2009) Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. Pediatr Crit Care Med 10:256-259. doi: 10.1097/PCC. 0b013e31819a383c
25. Slack JP, Brockhoff A, Batram C, Menzel S, Sonnabend C, Born S, Mercedes Galindo M, Kohl S, Thalmann S, Ostopovici-Halip L, Simons CT, Ungureano I, Duineveld K, Bologa CG, Behrens M, Furrer S, Oprea TI, Meyerhof W (2010) Modulation of bitter taste perception by a small molecule hTAS2R antagonist. Curr Biol 20:1104-1109. doi: 10.1016/j.cub.2010.04.043
26. Spomer N, Klingmann V, Stoltenberg I, Lerch C, Meissner T, Breitkreutz J (2012) Acceptance of uncoated mini-tablets in young children - results from a prospective exploratory cross-over study. Arch Dis Child 97:283-286. doi: 10.1136/archdischild-2011-300958
27. Thomson SA, Tuleu C, Wong IC, Keady S, Pitt KG, Sutcliffe AG (2009) Minitablets: new modality to deliver medicines to preschool-aged children. Pediatrics 123(2):e235-e238. doi: 10.1542/peds.2008-2059
28. Turner M, Storme T (2012) European Study for Neonatal Excipient Exposure (ESNEE). Eur J Hosp Pharm. doi: 10.1136/ejhpharm-2012-000065
29. Van Riet-Nales DA, Schobben AF, Egberts TC, Rademaker CM (2010) EFFECTS of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: a systematic literature review. Clin Ther 32:924-938. doi: 10.1016/j.clinthera.2010.05.005
30. Walsh J, Bickmann D, Breitkreutz J, Chariot-Goulet M (2011) Delivery devices for the administration of paediatric formulations: overview of current practice, challenges and recent developments. Int J Pharm 415: 221-231. DOI: http://dx.doi.org/10.1016/j.ijpharm.2011.05.048
31. Whittaker A, Currie AE, Turner MA, Field DJ, Mulla H, Pandya HC (2009) Toxic additives in medication for preterm infants. Arch Dis Child Fetal Neonatal Ed 94:F236-F240. doi: 10.1136/adc.2008.146035
32. WHO Development of paediatric medicines: points to consider in pharmaceutical development, Working document QAS/08.257/Rev.3 October 2011. Available via http://www.who.int/medicines/areas/quality-safety/quality- assurance/Rev3-PaediatricMedicinesDevelopment-QAS08-257Rev3-17082011.pdf. Accessed 06 september 2012
33. Woertz K, Tissen C, Kleinebudde P, Breitkreutz J (2010) Rational development of taste masked oral liquids guided by an electronic tongue. Int J Pharm 400:114-123. doi: 10.1016/j.ijpharm.2010.08.042
34. Woertz K, Tissen C, Kleinebudde P, Breitkreutz J (2011) Taste sensing systems (electronic tongues) for pharmaceutical applications. Int J Pharm 417:256-271. doi: 10.1016/j.ijpharm.2010.11.028
35. Zuccotti GV, Fabiano V (2011) Safety issues with ethanol as an excipient in drugs intended for pediatric use. Expert Opin Drug Saf 10:499-502. doi: 10.1517/14740338.2011.565328